Mefloquine is used for: Malaria.
Recorded in the NepalDoc medicine catalog for Mefloquine.
Treatment of Acute Malaria Infections Mefloquine hydrochloride tablets are indicated for the treatment of mild to moderate acute malaria caused by mefloquine-susceptible strains of P. falciparum (both chloroquine-susceptible and resistant strains) or by Plasmodium vivax.
From the U.S. FDA-approved label for Mefloquine. Full label: DailyMed.
Treatment of Acute Malaria Infections Mefloquine hydrochloride tablets are indicated for the treatment of mild to moderate acute malaria caused by mefloquine-susceptible strains of P. falciparum (both chloroquine-susceptible and resistant strains) or by Plasmodium vivax. There are insufficient clinical data to document the effect of mefloquine in malaria caused by P. ovale or P. malariae. Note: Patients with acute P.
From the U.S. FDA-approved label for Mefloquine. Full label: DailyMed.
Malaria Treatment in Adults Treatment of mild to moderate malaria in adults caused by mefloquine-susceptible strains of P. falciparum or by P. vivax: Dosage: Five tablets (1250 mg) mefloquine hydrochloride to be given as a single oral dose.
Directions from the U.S. FDA-approved label for Mefloquine — your doctor or pharmacist may advise differently.
Use of mefloquine hydrochloride tablets is contraindicated in patients with a known hypersensitivity to mefloquine or related compounds (e.g., quinine and quinidine) or to any of the excipients contained in the formulation. Mefloquine hydrochloride tablets should not be prescribed for prophylaxis in patients with active depression, a recent history of depression, generalized anxiety disorder, psychosis, schizophrenia or other major psychiatric disorders, or with a history of convulsions.
Excerpt from the U.S. FDA-approved label for Mefloquine. Talk to a pharmacist or doctor before use.
In case of life-threatening, serious or overwhelming malaria infections due to P. falciparum, patients should be treated with an intravenous antimalarial drug. Following completion of intravenous treatment, mefloquine may be given to complete the course of therapy. QTc Interval Prolongation and Drug Interactions Halofantrine should not be administered with mefloquine or within 15 weeks of the last dose of mefloquine due to the risk of a potentially fatal prolongation of the QTc interval (see CLINICAL PHARMACOLOGY, Pharmacokinetics, Elimination ).
Warnings and precautions excerpt from the U.S. FDA-approved label for Mefloquine — not a complete list. Talk to a pharmacist or doctor before use.
Clinical At the doses used for treatment of acute malaria infections, the symptoms possibly attributable to drug administration cannot be distinguished from those symptoms usually attributable to the disease itself. Among subjects who received mefloquine for prophylaxis of malaria, the most frequently observed adverse experience was vomiting (3%).
Excerpt from the U.S. FDA-approved label for Mefloquine — not a complete list. Talk to a pharmacist or doctor about side effects.
3 brands · 3 makers in the NepalDoc catalog — see the full Mefloquine guide →
Store at 20° to 25°C (68° to 77°F). Keep this and all medications out of the reach of children.
Storage information from the U.S. FDA-approved label for Mefloquine.
What is Mefliam?
Mefliam 250mg Tablet is a Mefloquine medicine made by Cipla Ltd. It comes as 250mg Tablet.
What is Mefliam used for?
Mefloquine is used for Malaria.
What is the generic name of Mefliam?
The generic name of Mefliam is Mefloquine.
Which brands of Mefloquine are available in Nepal?
3 brands of Mefloquine are listed in the NepalDoc catalog, from 3 makers — including Larimef 250mg Tablet, Mefloc 250mg Tablet.
What are the side effects of Mefloquine?
Clinical At the doses used for treatment of acute malaria infections, the symptoms possibly attributable to drug administration cannot be distinguished from those symptoms usually attributable to the disease itself.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
